Opportunity Information: Apply for PAR 10 018
Apply for PAR 10 018
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs 93.399 Cancer Control.
- This funding opportunity was created on Oct 30, 2009 and posted on Oct 30, 2009.
- Applicants must submit their applications by Jan 7, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $2,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: Special district governments Public housing authorities/Indian housing authorities Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Independent school districts Public and State controlled institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) State governments County governments For profit organizations other than small businesses Small businesses Private institutions of higher education.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, titled "Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01)" (Funding Opportunity Number PAR-10-018), is an NIH grant program led by the National Institute on Drug Abuse (NIDA) with participation from the National Cancer Institute (NCI), and with involvement from the Office of Behavioral and Social Sciences Research (OBSSR). The central goal is to speed up progress in substance-use and related behavioral health research by funding projects that rely on innovative secondary analyses of existing data rather than collecting entirely new datasets. In other words, the program is designed for researchers who can ask strong new questions, apply improved methods, or link and harmonize datasets to generate new knowledge using data that already exist in public repositories or are privately held by investigators.
The scientific focus is broad but clearly centered on substance use and its consequences across the lifespan and across populations. The announcement defines drug-using behaviors expansively to include alcohol, tobacco, and other drugs, and it also emphasizes HIV risk behaviors and related disorders. Supported projects can examine etiologic and epidemiologic questions (how and why behaviors begin, spread, change, and cluster in individuals and communities), as well as prevention and treatment topics (what works, for whom, and under what conditions). A key additional emphasis is health services research tied to these behaviors, including how people access prevention and treatment services, the quality of those services, and the costs involved. The intention is to leverage the depth of existing social science and behavioral data to produce findings that can meaningfully inform public health policy, clinical practice, and program implementation.
A distinctive feature of the opportunity is its encouragement of coordinated analyses across multiple substance-abuse-related datasets. Applicants are encouraged to work with data that are publicly available or with datasets maintained privately by a principal investigator, and to consider strategies such as combining complementary studies, conducting harmonized analyses across cohorts, or using advanced analytic approaches that extract more value from existing information. This emphasis reflects a practical public health logic: high-quality epidemiologic, prevention, and treatment studies already exist, and reusing them intelligently can deliver faster and often more cost-effective insights than starting from scratch, especially when the analyses are designed to answer timely questions or resolve inconsistencies across prior studies.
The mechanism of support is the NIH R01 research project grant, which typically funds discrete, hypothesis-driven or well-justified exploratory research projects led by a principal investigator. For this specific announcement, NIDA indicated a set-aside of approximately 2 million dollars for fiscal year 2010, with an anticipated 5 to 8 awards, contingent on funds being available and on the receipt of enough high-quality, meritorious applications. The listing includes an award ceiling of 250,000 (as provided in the source summary), which signals an expectation that projects are appropriately scoped for secondary data analysis work, where major new data collection costs are generally not the focus.
Eligibility is intentionally broad, spanning many types of institutions and organizations capable of conducting rigorous research. Eligible applicants include federal, state, county, and local governments; public and private institutions of higher education; nonprofit organizations (including those with and without 501(c)(3) status, other than institutions of higher education); for-profit organizations (including small businesses and other for-profits); public housing authorities; independent school districts; and a range of tribal governments and tribal organizations. The announcement also explicitly notes additional eligible entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based and community-based organizations, U.S. territories or possessions, regional organizations, and foreign (non-U.S.) entities. The opportunity states there is no cost-sharing or matching requirement, which reduces barriers for applicants who may not have access to substantial non-federal resources.
Administratively, the opportunity was posted on October 30, 2009, and reflects an original and current closing date of January 7, 2013, with an archive date of February 7, 2013, indicating that it was a time-limited program announcement for that period. The program is cataloged under CFDA numbers 93.279 (Drug Abuse and Addiction Research Programs) and 93.399 (Cancer Control), aligning with the involvement of NIDA and NCI and underscoring the intersection between substance use research and broader chronic disease and cancer control concerns, particularly relevant for tobacco and alcohol. The official NIH announcement page is referenced through the NIH grants guide link associated with PAR-10-018, and general technical contact support is routed through the NIH Office of Extramural Research webmaster for access and linking issues.
Taken together, PAR-10-018 is essentially a call for well-designed, high-impact research that makes smarter use of data already in hand. It prioritizes strong, methodologically sound secondary analyses that can quickly advance understanding of substance use, HIV-related risk, prevention and treatment effectiveness, and the real-world delivery, quality, and costs of related health services, while enabling a wide range of applicant organizations to participate in producing actionable public health evidence.
Frequently Asked Questions (FAQs)
What is the title and funding opportunity number for this grant?
The opportunity is titled "Accelerating the Pace of Drug Abuse Research Using Existing Epidemiology, Prevention, and Treatment Research Data (R01)" and the Funding Opportunity Number is PAR-10-018.
Which agency and NIH institute lead this funding opportunity?
This is an NIH funding opportunity led by the National Institute on Drug Abuse (NIDA).
Are other NIH components involved?
Yes. The National Cancer Institute (NCI) participates, and the Office of Behavioral and Social Sciences Research (OBSSR) is involved.
What is the main goal of PAR-10-018?
The central goal is to accelerate progress in substance-use and related behavioral health research by funding innovative secondary analyses of existing data, rather than projects that rely on collecting entirely new datasets.
What does "secondary analysis" mean in the context of this program?
In this program, secondary analysis refers to answering strong new research questions using data that already exist, such as data available in public repositories or datasets privately held by investigators, potentially using improved methods or by linking and harmonizing datasets.
Does this opportunity support collecting new data?
The opportunity is designed to prioritize research that uses existing data rather than collecting entirely new datasets. The emphasis is on extracting new knowledge from data already in hand.
What kinds of data sources can be used?
Applicants are encouraged to use data that are publicly available and/or datasets maintained privately by a principal investigator, as long as the project is built around secondary analysis of those existing resources.
What scientific areas or topics are in scope?
The scope is broad but centered on substance use and its consequences across the lifespan and across populations, including epidemiology, etiology, prevention, treatment, HIV risk behaviors, and related disorders.
How does the announcement define "drug-using behaviors"?
The announcement uses an expansive definition that includes alcohol, tobacco, and other drugs.
Are HIV risk behaviors included within the scientific interests?
Yes. The opportunity emphasizes HIV risk behaviors and related disorders as part of the supported research scope.
What types of research questions are encouraged?
Supported projects can address etiologic and epidemiologic questions (how and why behaviors begin, spread, change, and cluster in individuals and communities), as well as prevention and treatment questions (what works, for whom, and under what conditions).
Is health services research an allowable focus under this program?
Yes. A specific emphasis is placed on health services research tied to substance-use and related behaviors, including access to prevention and treatment services, the quality of those services, and the costs involved.
Does the program encourage analysis across multiple datasets?
Yes. A distinctive feature is the encouragement of coordinated analyses across multiple substance-abuse-related datasets, including strategies like combining complementary studies and conducting harmonized analyses across cohorts.
What does it mean to "link and harmonize" datasets for this opportunity?
Based on the announcement description, linking and harmonizing refers to aligning variables, measures, and analytic approaches across more than one existing dataset so that coordinated or pooled analyses can produce new insights and help resolve inconsistencies across prior studies.
What grant mechanism is used for this funding opportunity?
The mechanism of support is the NIH R01 Research Project Grant.
What kind of project is an R01 intended to support here?
Within the context described, the R01 is used to support discrete, hypothesis-driven or well-justified exploratory research projects led by a principal investigator, focused on secondary analysis of existing epidemiology, prevention, and treatment research data.
How much funding was expected to be available and how many awards were anticipated?
NIDA indicated a set-aside of approximately $2 million for fiscal year 2010 and anticipated making 5 to 8 awards, contingent on the availability of funds and the submission of enough high-quality, meritorious applications.
Is there an award ceiling mentioned for this opportunity?
Yes. The source summary notes an award ceiling of $250,000, signaling an expectation that projects are appropriately scoped for secondary data analysis work.
Who is eligible to apply?
Eligibility is broad and includes federal, state, county, and local governments; public and private institutions of higher education; nonprofit organizations (including those with and without 501(c)(3) status, other than institutions of higher education); for-profit organizations (including small businesses and other for-profits); public housing authorities; independent school districts; tribal governments and tribal organizations; U.S. territories or possessions; regional organizations; and foreign (non-U.S.) entities.
Are certain institution types explicitly called out as eligible?
Yes. The announcement explicitly notes eligibility for entities such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Alaska Native and Native Hawaiian Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), and faith-based and community-based organizations.
Are foreign (non-U.S.) organizations eligible?
Yes. The opportunity states that foreign (non-U.S.) entities are eligible applicants.
Is cost sharing or matching required?
No. The opportunity states there is no cost-sharing or matching requirement.
When was the opportunity posted and what are the key dates listed?
The opportunity was posted on October 30, 2009. The original and current closing date listed is January 7, 2013, and the archive date is February 7, 2013.
Which CFDA numbers are associated with this program?
The program is cataloged under CFDA 93.279 (Drug Abuse and Addiction Research Programs) and 93.399 (Cancer Control).
Why is the National Cancer Institute (NCI) involved?
Based on the information provided, NCI participation aligns with the intersection of substance use research and broader chronic disease and cancer control concerns, particularly in areas relevant to tobacco and alcohol.
What is the intended benefit of reusing existing studies and datasets?
The intent is to deliver faster and often more cost-effective insights than starting new studies from scratch, especially when analyses are designed to answer timely questions, apply improved methods, or resolve inconsistencies across prior studies.
Where is the official announcement referenced?
The official NIH announcement page is referenced through the NIH Grants Guide link associated with PAR-10-018.
Where can applicants get technical help related to access or linking issues?
General technical contact support for access and linking issues is routed through the NIH Office of Extramural Research (OER) webmaster.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: Technologies for Image Guided Interventions (R01)
Previous opportunity: Hispanic Serving Institutions Education Grants Program (HSI)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 10 018
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 10 018) also looked into and applied for these:
| Funding Opportunity |
|---|
| Drug Abuse Dissertation Research Epidemiology, Prevention, Treatment, Services, and/or Women and Sex/Gender Differences (R36) Apply for PAR 10 020 Funding Number: PAR 10 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| AIDS Science Track Award for Research Transition (R03) Apply for PAR 10 021 Funding Number: PAR 10 021 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| State and Community Tobacco Control Policy and Media Research (U01) Apply for RFA CA 10 008 Funding Number: RFA CA 10 008 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Effectiveness Research on Smoking Cessation in Hospitalized Patients (U01) Apply for RFA HL 10 020 Funding Number: RFA HL 10 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R01) Apply for PA 10 025 Funding Number: PA 10 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development, Application, and Evaluation of Prediction Models for Cancer Risk and Prognosis (R21) Apply for PA 10 026 Funding Number: PA 10 026 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (Phased Innovation Award R21/R33) Apply for PAR 10 024 Funding Number: PAR 10 024 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R21) Apply for PA 10 023 Funding Number: PA 10 023 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Epigenetic Approaches in Cancer Epidemiology (R01) Apply for PA 10 031 Funding Number: PA 10 031 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Epigenetic Approaches in Cancer Epidemiology (R21) Apply for PA 10 032 Funding Number: PA 10 032 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Transdisciplinary Research in Energetics and Cancer (U54) Apply for RFA CA 10 006 Funding Number: RFA CA 10 006 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Prioritizing Molecular Targets for Cancer Prevention with Nutritional Combinations (R01) Apply for PA 10 035 Funding Number: PA 10 035 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Dissemination and Implementation Research in Health (R01) Apply for PAR 10 038 Funding Number: PAR 10 038 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Dissemination and Implementation Research in Health (R21) Apply for PAR 10 040 Funding Number: PAR 10 040 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Dissemination and Implementation Research in Health (R03) Apply for PAR 10 039 Funding Number: PAR 10 039 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Critical Illness and Injury in Aging (R03) Apply for PA 10 043 Funding Number: PA 10 043 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Critical Illness and Injury in Aging (R01) Apply for PA 10 042 Funding Number: PA 10 042 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Critical Illness and Injury in Aging (R21) Apply for PA 10 044 Funding Number: PA 10 044 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Cancer Immunotherapy Trials Network (U01) Apply for RFA CA 10 007 Funding Number: RFA CA 10 007 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Research on Integrity in Collaborative Research (R21) Apply for RFA RR 10 001 Funding Number: RFA RR 10 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 10 018", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
